Skip to main content

Advertisement

Log in

To dispense or not to dispense? Ethical case decision-making in pharmacy practice

  • Commentary
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

In daily practice, pharmacists are regularly confronted with moral problems in which deciding what to do is not always a straightforward decision. In this contribution we show how the use of a specific method for moral deliberation can (in retrospect or prospective) aid moral judgements. We use the case of dispensing isotretinoin to demonstrate one ethical reflection method, namely the Utrecht Method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The Centre for Bioethics and Health Law is currently the Ethics Institute.

  2. For a justification of this standard, see Den Hartogh who argues that a physician is involved in a specific project, and it is contrary to the project to facilitate the birth of a life marred by serious defects. These considerations relate to the quality of life of any future child whomever that may be [14].

References

  1. Cooper RJ, Bissell P, Wingfield J. Ethical decision-making, passivity, and pharmacy. J Med Ethics. 2008;34:441–5.

    Article  CAS  PubMed  Google Scholar 

  2. Charter Professionalism of the Pharmacist. Royal Dutch Pharmacist Association. Dec 2012. http://www.knmp.nl/praktijkvoering/professionaliteit/handvest-van-de-apotheker. Accessed 14 Dec 2014.

  3. Steinkamp N, Gordijn B. Ethical case deliberation on the ward. A comparison of four methods. Med Health Care Philos. 2003;6:235–46.

    Article  PubMed  Google Scholar 

  4. Rutgers B, Heeger R. The reflective equilibrium method of moral reasoning in teaching animal and veterinary ethics. In: Marie M, Edwards S, et al. editors. Animal bioethics, principles and teaching methods. Wageningen University Press, Wageningen; 2005. pp. 329–42.

  5. Bolt LLE, Verweij MF, van Delden JJM. Ethiek in praktijk. Assen: Van Gorcum; 2010.

    Google Scholar 

  6. European Medicines Agency (EMAE). EMEA/CPMP/2811/03. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Isotretinoin_29/WC500010881.pdf. Accessed 19 Jan 2015.

  7. Zomerdijk IM, Ruiter R, Houweling LMA, Herings RMC, Sturkenboom MCJM, Straus SMJM, et al. Isotretinoin exposure during pregnancy: a population-based study in The Netherlands. BMJ. 2014. BMJ Open 2014; 4:e005602. doi:10.1136/bmjopen-2014-005602.

  8. Lammer E, Chen D, Hoar R, Agnish N, Benke P, Braun L, et al. Retinoic acid embryopathy. NEJM. 1985;313:837–41.

    Article  CAS  PubMed  Google Scholar 

  9. Schaefer C, Meister R, Weber-Schoendorfer C. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy. Arch Gynecol Obstet. 2010;281:221–7.

    Article  PubMed  Google Scholar 

  10. Crijns HJMJ, van Rein N. Gispen-de Wied CC, Straus SM, de Jong-van den Berg LTW. Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study. Pharmacoepidemiol Drug Saf. 2012;21:1060–6.

    Article  PubMed  Google Scholar 

  11. Crijns I, Straus S, Luteijn M, Gispen-de Wied C, Raine J, de Jong-van den Berg L. Implementation of the Harmonized EU Isotretinoin Pregnancy Prevention Programme. A Questionnaire Survey among European Regulatory Agencies. Drug Saf. 2012;35(1):27–32.

    Article  CAS  PubMed  Google Scholar 

  12. Hope T, McMillan J. Physicians’ duties and the non-identity problem. Am J Bioeth. 2012;12(8):21–9.

    Article  PubMed  Google Scholar 

  13. NVOG (Nederlandse Vereniging voor Obstetrie & Gynaecologie). Modelprotocol Mogelijke morele contra-indicaties bij vruchtbaarheidsbehandelingen. Utrecht. 2010. http://www.nvog.nl/Sites/Files/0000000935_NVOGModelprotocolMogelijkeMoreleContraindicatiesVruchtbaarheidsbehandelingen2010.pdf. Accessed 26 Apr 2015.

  14. den Hartogh G. Het filosofisch gehalte van de medische ethiek. De casus “wrongful life”. In: Braeckman J, de Reuver B, Vervisch T, editors. Ethiek van DA tot 9/11. Amsterdam; 2005. pp. 15–40.

  15. Schermer M. Health, happiness and human enhancement—dealing with unexpected effects of deep brain stimulation. Neuroethics. 2013;6:435–45.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Hoven M van den, Kole J. Distance, dialogue and reflection: interpersonal reflective equilibrium as method for professional ethics education. J Moral Educ. 2015;44:145–64.

Download references

Acknowledgments

We thank the anonymous reviewers for their constructive comments.

Funding

None.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ineke Bolt.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bolt, I., van den Hoven, M., Blom, L. et al. To dispense or not to dispense? Ethical case decision-making in pharmacy practice. Int J Clin Pharm 37, 978–981 (2015). https://doi.org/10.1007/s11096-015-0170-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-015-0170-8

Keywords

Navigation